Stock Market News
Latest financial news · Updated Aug 11, 2026
Rocket Lab’s $2.36 Billion Backlog Says the Neutron Delay Doesn’t Matter — Here’s Why
The panel consensus is that Rocket Lab's (RKLB) recent financials show strong growth, but the key risk lies in the …
DIA, GS, TRV, AXP: ETF Inflow Alert
The panelists generally agree that while inflows into DIA suggest momentum, the lack of fundamental catalysts and the concentration risk …
Zelensky Claims North Korea Sending Up To 50K Troops To Russia, Presses Seoul To Send Missiles
Zelensky's unconfirmed claims of increased North Korean troop involvement and missile use in Ukraine are likely information warfare to pressure …
Wheat Futures Volatile As Black Sea Crisis And Hormuz Chokepoint Spark Concerns
The panel agrees that near-term supply risks from Black Sea attacks and Hormuz tensions are driving wheat prices, with the …
Nvidia Confirms Huge AI Funding Deal. These Financial Stocks Jump.
The panel discusses Nvidia's $500B AI infrastructure funding pact with financial firms, with mixed views on its implications for Nvidia …
Jensen Huang’s $500 Billion Wall Street AI Deal Sounds Brilliant — Until You Consider the Risks
The panel consensus is that Nvidia's $500B MOU with major investors signals significant institutional interest in AI infrastructure, but the …
Broadcom vs. Marvell: Which Stock Has More AI Upside?
The panel discusses the potential of AVGO and MRVL in the custom silicon and networking space, but consensus is mixed …
Despite More Tech Investments, Coca-Cola Stock Is a Top 5 Holding in Berkshire Hathaway's Portfolio
Despite Coca-Cola's (KO) significant dividend payout and historical performance, panelists express concerns about its future growth prospects, structural headwinds, and …
Brown-Forman Corporation (BF-B) Says No to Sazerac’s $15 Billion Takeover Bid, Again
The panel unanimously agrees that Brown-Forman's rejection of Sazerac's $15B bid is a bearish signal, with key concerns being the …
Eli Lilly and Company (LLY) vs. Novo Nordisk A/S (NVO): Is Lilly Pulling Ahead in the $100 Billion Obesity Market?
The panelists agree that while Lilly (LLY) has shown impressive growth and superior efficacy in weight loss, the market is …
16 Wall Street Analysts Couldn't Disagree More on Sandisk's Price Target
The panelists generally agree that Western Digital's (WDC) 2,800% run is unsustainable due to its high P/E ratio, cyclical nature, …
Is Lam Research, KLA, or Applied Materials the Best Chip Equipment Buy? Jim Cramer Weighs In
The panelists agreed that while LRCX, KLAC, and AMAT benefit from strong demand in data centers and AI, their cyclical …